KEGG   DRUG: Lifastuzumab vedotinHelp
Entry
D11238                      Drug                                   

Name
Lifastuzumab vedotin (USAN/INN)
Formula
C6504H10028N1744O2018S46. (C68H106N11O15)n
Efficacy
Antineoplastic
Comment
Monoclonal antibody
Target
SLC34A2 [HSA:10568] [KO:K14683]
TUBB [HSA:10381 10382 10383 203068 347688 347733 7280 81027 84617] [KO:K07375]
  Pathway
hsa04540  Gap junction
hsa04928  Parathyroid hormone synthesis, secretion and action
hsa04978  Mineral absorption
Brite
Target-based classification of drugs [BR:br08310]
 Transporters
  Solute carrier family
   SLC34
    SLC34A2
     D11238  Lifastuzumab vedotin (USAN/INN)
 Not elsewhere classified
  Cellular process
   Cytoskeleton
    TUBB
     D11238  Lifastuzumab vedotin (USAN/INN)
BRITE hierarchy
Other DBs
CAS: 1401812-88-1
PubChem: 384585216
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system